SCHEMBL7763906

SCHEMBL7763906

CCCCCCCCCCCCSCC(NC(=O)C(F)(F)F)C(=O)O.O=C(CCl)CCl

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CES1 P23141 5/20 0.46
FAAH O00519 5/20 0.46
CES2 O00748 3/20 0.46
PLA2G6 O60733 1/20 0.46
EPHX1 P07099 1/20 0.41
GMNN O75496 1/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
MAPT P10636 1/20 0.40
THRB P10828 1/20 0.40
CYP2C9 P11712 1/20 0.40
BLM P54132 1/20 0.40
HSD17B10 Q99714 1/20 0.40
NOD1 Q9Y239 3/20 0.36
ICMT O60725 1/20 0.35
ASAH1 Q13510 1/20 0.34
PLA2G2A P14555 2/20 0.33
PLA2G5 P39877 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7763912 0.90 CES1 (0.48) CES1FAAHCES2PLA2G6EPHX1
SCHEMBL7763910 0.89 CES1 (0.45) CES1FAAHCES2PLA2G6EPHX1
SCHEMBL8015239 0.81 PPARG (0.47) GMNNTP53POLBMAPTTHRB
SCHEMBL7762822 0.80 GMNN (0.39) FAAHCES2EPHX1GMNNTP53
SCHEMBL7757470 0.78 HDAC3 (0.47) CYP2C9HSD17B10ICMT
SCHEMBL9119016 0.76 ICMT (0.53) CES1FAAHCES2PLA2G6GMNN
SCHEMBL9545182 0.76 ICMT (0.53) CES1FAAHCES2PLA2G6GMNN
SCHEMBL9545188 0.76 ICMT (0.53) CES1FAAHCES2PLA2G6GMNN
SCHEMBL19927712 0.76 ICMT (0.53) CES1FAAHCES2PLA2G6GMNN
SCHEMBL19927710 0.76 ICMT (0.53) CES1FAAHCES2PLA2G6GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251882-B1 TREATING LEUKEMIA, BREAST CANCER, PROSTATE CANCER, OR BRAIN TUMOR PARKER HUGHES INSTITUTE 2001-06-26 US disclosed
EP-1091934-A2 ALKYL KETONES AS POTENT ANTI-CANCER AGENTS Parker Hughes Institute (US) 2001-04-18 EP disclosed
WO-2000000469-A2 ALKYL KETONES AS POTENT ANTI-CANCER AGENTS PARKER HUGHES INSTITUTE (US) 2000-01-06 WO disclosed